Comparative Efficacy and Acceptability of Noninvasive Brain Stimulation for Migraine: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Abstract
Objective: This network meta-analysis (NMA) aimed to compare and rank the efficacy and acceptability of different noninvasive brain stimulation (NIBS) techniques for migraine treatment in adults.
Method: We systematically searched PubMed, Web of Science, Embase, Cochrane Library, and ClinicalTrials.gov through October 13, 2025, for randomized controlled trials (RCTs) in adults with migraine. The primary outcomes were changes in monthly migraine days (MMD) and dropout rates, analyzed using a random-effects model. Heterogeneity was assessed with I2, risk of bias (RoB) with the Cochrane RoB 2 tool, and evidence quality with Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria.
Result: This NMA integrated data from 28 RCTs encompassing 1920 participants. Among the evaluated interventions, visual cortex (V1) transcranial direct current stimulation (tDCS) over Oz-Cz (VC-tDCS-OzCz)-an anodal protocol targeting the V1-ranked highest for reducing MMD (mean difference [MD] = -1.75; 95% CI: -3.37 to -0.13; surface under the cumulative ranking curve [SUCRA]: 83.5%). For acceptability, only transcutaneous occipital nerve stimulation (tONS) significantly reduced dropout rates versus sham (risk ratio [RR] = 0.36, 95% CI: 0.16-0.82).
Conclusion: Among the interventions evaluated, VC-tDCS-OzCz showed the largest reduction in MMD. However, these findings are based on predominantly moderate-to-low certainty evidence (GRADE), substantial heterogeneity, and a…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,920 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.